WHO ICTRP trial
A Double-Blind Comparison of the Safety and Efficacy of Dysport® and BOTOX®…
EUCTR2005-005235-96-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-005235-96-GB |
|---|---|
| Public title | A Double-Blind Comparison of the Safety and Efficacy of Dysport® and BOTOX® (Botulinum Toxin Type A) in the Treatment of Female Subjects with Severe Glabellar Rhytids |
| Scientific title | A Double-Blind Comparison of the Safety and Efficacy of Dysport® and BOTOX® (Botulinum Toxin Type A) in the Treatment of Female Subjects with Severe Glabellar Rhytids |
| Primary sponsor | Cranley Clinic |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Severe glabellar rhytids |
| Interventions | Trade Name: BOTOX® Product Name: BOTOX® Product Code: N/A Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Clostridium botulinum type A neurotoxin complex CAS Number: N/A Current Sponsor code: BOTOX Other… |
| Registration date | Nov 11, 2005 |
| Target size | 60 |
| Secondary IDs | BTX0506 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: